Skip Navigation Links
Centers for Disease Control and Prevention
 CDC Home Search Health Topics A-Z
National Center for HIV/AIDS, Viral Hepatitis, STD and TB Prevention
  Division of Sexually Transmitted Diseases
    Program and Training Branch
STD Prevention STD Training Home Links Contact Us Glossary 
STD Prevention
Self-Study Modules
Gonorrhea
Course Objective
Line separator
Target audience
Line separator
Continuing education
Lessons
Line separator
Epidemiology
Line separator
Pathogenesis and microbiology
Line separator
Clinical manifestations and sequelae
Line separator
Diagnostic methods
Line separator
Patient management / treatment
Line separator
Patient counseling and education
Line separator
Partner management / Public health
Line separator
Case study
Line separator
Resources
Line separator
 
 
 

Self-Study STD Module - Gonorrhea

Diagnostic Methods

A complex array of technologies is available for laboratory diagnosis of Neisseria gonorrhoeae. This technology has changed significantly over the past 10 years and represents a vast improvement in sensitivity and specificity. Tests include both culture and non-culture diagnostics.

The most commonly used newer non-culture tests are nucleic acid detection tests, which include both amplified and non-amplified tests and are used for both diagnosis and screening. Gram stain, another non-culture test, is used for the diagnosis of gonorrhea in symptomatic males.

Culture

Culture is the historical standard for detection of N. gonorrhoeae. It has several advantages over non-culture tests, including:

  • Low cost
  • Suitable for a variety of specimen sites
  • Antimicrobial susceptibility testing can be performed

Thayer-Martin medium is one example of a medium used for N. gonorrhoeae culture. Direct inoculation of culture plates with swab specimens is best. The inoculated culture plate should be promptly placed into a CO2-enriched (3%-10%) environment and incubated at 35º-37º C.

To assist in diagnosis, culture samples should be taken from anatomic sites in response to complaints, clinical findings, and exposure history.

In men:

  • The urethra should be tested routinely.
  • The pharynx and rectum should be tested depending on symptoms and exposure history, including history of receptive anal sex or performing fellatio or cunnilingus.

In women:

  • The cervix should be tested routinely.
  • The pharynx and rectum should be tested if there is a history of receptive anal sex or performing fellatio or cunnilingus.
  • Skene’s glands or Bartholin’s glands may be cultured if overt exudate is expressed.
  • The vagina or urethra may be tested if the cervix is absent.
 
Click here for a Study Question
 
 
Page 8 of 16 BackStatusStatusNext
Page last modified: June 22, 2009
Page last reviewed: June 22, 2009

Content Source:Division of STD Prevention, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention

 


STD Home
| STD Index

CDC Home | Search | Health Topics A-Z

Centers for Disease Control and Prevention
National Center for HIV/AIDS, Viral Hepatitis, STD and TB Prevention
     Division of Sexually Transmitted Diseases Prevention